Sign Up Today and Learn More About Character Biosciences Stock
Invest in or calculate the value of your shares in Character Biosciences or other pre-IPO companies through EquityZen's platform.
Character Biosciences Stock
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
About Character Biosciences Stock
Founded
2018
Headquarters
Jersey City, NJ, US
Industries
Software, Artificial Intelligence, Data and Analytics
Character Biosciences Press Mentions
Stay in the know about the latest news on Character Biosciences
The Week’s Biggest Funding Rounds: Fleetio And Mercury Nab Massive Rounds
news • Mar 28, 2025
New York Startup Funding Off To A Slow Start In 2025
news • Mar 27, 2025
Financings for March 26, 2025
bioworld • Mar 27, 2025
Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases
biospace • Mar 26, 2025
Seeing a Better Way for Eye Drug R&D, Character Bio Lands $93M for Two Trials in Dry AMD
medcitynews • Mar 26, 2025
Character Biosciences Management
Leadership team at Character Biosciences
Co-Founder, Chief Executive Officer
Cheng Zhang
VP, Data Science & Machine Learning
Benjamin Glicksberg
Join now and verify your accreditation status to gain access to:
- Character Biosciences Current Valuation
- Character Biosciences Stock Price
- Character Biosciences Management
- Available deals in Character Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Character Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Character Biosciences Revenue and Financials
- Character Biosciences Highlights
- Character Biosciences Business Model
- Character Biosciences Risk Factors
- Character Biosciences Research Report from SACRA Research
Trading Character Biosciences Stock
How to invest in Character Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Character Biosciences through EquityZen funds. These investments are made available by existing Character Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Character Biosciences stock?
Shareholders can sell their Character Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."